Works matching IS 21534888 AND DT 2020 AND VI 11 AND IP 2
Results: 22
Encorafenib plus Cetuximab Improves Quality of Life versus Standard of Care in Colorectal Cancer Associated with BRAF Mutation.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 22
- By:
- Publication type:
- Article
Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 21
- By:
- Publication type:
- Article
Using Data Analytics and Machine Learning to Decode Cycle Times: How Infusion Centers Benefit.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 19
- By:
- Publication type:
- Article
ASCO Updates Its Oncology Medical Home Payment Model, Putting Patient Needs Up Front.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 19
- By:
- Publication type:
- Article
“Unheard of” Results with Trastuzumab Deruxtecan in Metastatic HER2-Positive Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 18
- By:
- Publication type:
- Article
Sarclisa Newest Treatment Approved by the FDA for Patients with Multiple Myeloma.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 16
- Publication type:
- Article
Combination of NUC-1031 plus Cisplatin Shows Promise as First-Line Treatment for Advanced Biliary Tract Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 15
- By:
- Publication type:
- Article
Cabozantinib–Atezolizumab Combination Shows Activity in Difficult-to-Treat Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 14
- By:
- Publication type:
- Article
FDA Approves Nivolumab plus Ipilimumab for Hepatocellular Carcinoma.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 14
- Publication type:
- Article
FDA Approves Imfinzi as First-Line Treatment, with Chemotherapy, for Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 12
- Publication type:
- Article
MicroRNAs Have Promise as Biomarker in Testicular and Other Germ-Cell Tumors.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 12
- By:
- Publication type:
- Article
Interview with the Innovators.
- Published in:
- 2020
- Publication type:
- Interview
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 10
- By:
- Publication type:
- Article
De-escalating Chemotherapy Possible in Low-Risk Patients with Advanced Testicular Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 9
- By:
- Publication type:
- Article
Pharmaceutical Manufacturers’ Response to COVID-19.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 8
- By:
- Publication type:
- Article
Wholesale Supply Channels Addressing the Pandemic.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 8
- By:
- Publication type:
- Article
Comprehensive Cancer Care Systems.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 7
- By:
- Publication type:
- Article
Washington and Public Policy: The COVID-19 Pandemic.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 7
- By:
- Publication type:
- Article
PSMA-PET Scanning Wave of the Future in Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
AVBCC Webcast Highlights: COVID-19 Impact on the Cancer Care Delivery Ecosystem.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 1
- Publication type:
- Article
Tucatinib Fills Unmet Need in Heavily Pretreated HER2-Positive Metastatic Breast Cancer, Including Brain Metastasis.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
NCCN Issues Guidance for Cancer Care During the COVID-19 Pandemic.
- Published in:
- Value-Based Cancer Care, 2020, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article